Dr Reddys Laboratories (RDY) Construction in Progress (2016 - 2026)
Dr Reddys Laboratories (RDY) recorded quarterly Construction in Progress of $159.7 million in Q1 2026, down 42.35% quarter-over-quarter from $277.1 million in Q1 2025, and down 42.35% on a YoY basis from $277.1 million in Q1 2025.
Dr Reddys Laboratories (RDY) Construction in Progress (2016 - 2026) Analysis & Trends
Dr Reddys Laboratories' Construction in Progress history runs 11 years deep, the most recent figure standing at $159.7 million for Q1 2026.
- In Q1 2026, Construction in Progress fell 42.35% year-over-year to $159.7 million; the TTM figure through Mar 2026 stood at $159.7 million (down 42.35% YoY), while the FY2026 annual figure was $165.4 million, down 41.72% from the prior year.
- Construction in Progress was $159.7 million for Q1 2026 at Dr Reddys Laboratories, down from $277.1 million in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $277.1 million in Q1 2025 to a low of $118.6 million in Q1 2023.
- Historically, Construction in Progress has averaged $169.2 million across 5 years, with a median of $161.2 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Construction in Progress surged 70.32% in 2025, then slumped 42.35% in 2026.
- A 5-year view of Construction in Progress shows it stood at $170.2 million in 2022, then declined by 25.48% to $126.8 million in 2023, then rose by 28.28% to $162.7 million in 2024, then jumped by 70.32% to $277.1 million in 2025, then plunged by 42.35% to $159.7 million in 2026.
- The last three Construction in Progress figures came in at $159.7 million (Q1 2026), $277.1 million (Q1 2025), and $162.7 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Dr Reddys Laboratories | 122.03 Mn | -51.98 Mn | 368.55 Mn | 159.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159.73 Mn |
| Mar 31, 2025 | 277.08 Mn |
| Mar 31, 2024 | 162.68 Mn |
| Sep 30, 2023 | 126.81 Mn |
| Mar 31, 2023 | 118.63 Mn |
| Mar 31, 2022 | 170.17 Mn |
| Sep 30, 2021 | 158.86 Mn |
| Mar 31, 2021 | 130.83 Mn |
| Sep 30, 2020 | 98.20 Mn |
| Mar 31, 2020 | 60.24 Mn |
| Mar 31, 2019 | 66.98 Mn |
| Sep 30, 2018 | 108.58 Mn |
| Mar 31, 2018 | 119.35 Mn |
| Sep 30, 2017 | 91.50 Mn |
| Mar 31, 2017 | 91.03 Mn |
| Sep 30, 2016 | 102.74 Mn |
| Mar 31, 2016 | 98.23 Mn |